PREVALENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1 (HTLV-1) AND HTLV-2 INFECTION AMONG SPANISH DRUG-USERS MEASURED BY HTLV-1 ASSAY AND HTLV-1 AND HTLV-2 ASSAY

被引:24
作者
HENRARD, DR
SORIANO, V
ROBERTSON, E
GUTIERREZ, M
STEPHENS, J
DRONDA, F
MILES, F
PUJOL, E
BUYTENDORP, M
CASTRO, A
CHAN, E
VALLEJO, A
LLIBRE, J
MOTLEY, C
PRILLAMAN, J
CALDERON, E
LEAL, M
TUSET, C
MARTINEZZAPICO, R
CABALLERO, E
ORTIZ, R
EIROS, J
AGUILERA, A
ULLOA, F
MARTIN, AM
RODRIGUEZIGLESIAS, A
RIVERA, A
BOUZA, E
ESPARZA, B
MERINO, F
TOR, J
ESCUDERO, D
RIBERA, J
DELROMERO, J
RODRIGUEZ, C
PEDREIRA, J
HEREDIA, A
HEWLETT, I
GONZALEZLAHOZ, J
机构
[1] ABBOTT LABS,RETROVIRUS RES & DEV,ABBOTT PK,IL 60064
[2] INST SALUD CARLOS 3,MADRID,SPAIN
[3] HOSP PENITENCIARO,MADRID,SPAIN
[4] HOSP JUAN RAMON JIMENEZ,HUELVA,SPAIN
[5] HOSP JUAN CANALEJO,LA CORUNA,SPAIN
[6] HOSP ST JAUME,CALELLA,SPAIN
[7] US FDA,CTR BIOL,RETROVIRUS LAB,BETHESDA,MD 20014
关键词
D O I
10.1128/JCM.33.7.1735-1738.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection in 1992 and 1993 was determined by testing 2,152 specimens from injection drug users living in 11 geographic areas of Spain. Results obtained by an authentic HTLV-1 and -2 test were compared with those obtained by an HTLV-1 assay. HTLV infection was identified in 7 of 11 regions, with an overall prevalence of 2.5% (range, 0.4 to 11.5%). Fourty-four (81%) of 54 subjects were infected with HTLV-2; the viral strains in the remaining 10 subjects could not be serologically typed. Underestimation of HTLV infection because of the low sensitivities of HTLV-1 enzyme immunoassays for HTLV-2 antibody was relatively low (<20%). Therefore, previous epidemiologic findings generated with HTLV-1 enzyme immunoassays appear to be reasonably accurate. Our results suggest that the rate of HTLV infection may have been increasing recently among Spanish drug users.
引用
收藏
页码:1735 / 1738
页数:4
相关论文
共 18 条
[1]  
BLATTNER WA, 1990, HUMAN RETROVIROLOGY : HTLV, P251
[2]   COMPARISON OF 6 COMMERCIAL HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) ENZYME-IMMUNOASSAY KITS FOR DETECTION OF ANTIBODY TO HTLV-I AND HTLV-II [J].
COSSEN, C ;
HAGENS, S ;
FUKUCHI, R ;
FORGHANI, B ;
GALLO, D ;
ASCHER, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (03) :724-725
[3]   HUMAN T-LYMPHOTROPIC VIRUS (HTLV) TYPE-I AND TYPE-II - SEROPREVALENCE AMONG INTRAVENOUS-DRUG-USERS IN CONTINENTAL FRANCE [J].
COSTE, J ;
LEMAIRE, JM ;
COUROUCE, AM ;
CANAVAGGIO, M .
AIDS, 1993, 7 (03) :440-441
[4]   CHRONIC NEURODEGENERATIVE DISEASE ASSOCIATED WITH HTLV-II INFECTION [J].
HJELLE, B ;
APPENZELLER, O ;
MILLS, R ;
ALEXANDER, S ;
TORREZMARTINEZ, N ;
JAHNKE, R ;
ROSS, G .
LANCET, 1992, 339 (8794) :645-646
[5]  
KHABBAZ RF, 1990, NEW ENGL J MED, V326, P375
[6]   PATTERNS OF HIV-1 AND HTLV-I/II IN INTRAVENOUS DRUG-ABUSERS FROM THE MIDDLE ATLANTIC AND CENTRAL REGIONS OF THE USA [J].
LEE, HH ;
WEISS, SH ;
BROWN, LS ;
MILDVAN, D ;
SHORTY, V ;
SARAVOLATZ, L ;
CHU, A ;
GINZBURG, HM ;
MARKOWITZ, N ;
DESJARLAIS, DC ;
BLATTNER, WA ;
ALLAIN, JP .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (02) :347-352
[7]  
MAYER V, 1991, ACTA VIROL, V35, P472
[8]   TRANSMISSION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV) TYPE-II BY TRANSFUSION OF HTLV-I-SCREENED BLOOD PRODUCTS [J].
RIOS, M ;
KHABBAZ, RF ;
KAPLAN, JE ;
HALL, WW ;
KESSLER, D ;
BIANCO, C .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (01) :206-210
[9]  
ROBERTSON E, 1993, 1ST NAT C HUM RETR
[10]   HTLV-I IN SPAIN [J].
SORIANO, V ;
TOR, J ;
MONZON, M ;
GRAUS, JM ;
CLOTET, B ;
RIBASMUNDO, M .
LANCET, 1990, 336 (8715) :627-628